Early adopters are effectively using social media for patient recruitment and retention but in general the industry is fearful, a panelist at Patient Recruitment Outsourcing (PRO) 2011 said.
Clinical trial enrollment can be accelerated by better understanding patients and using EHRs to inform protocol design, panelists told an Outsourcing-Pharma conference.
Companies outsourcing patient recruitment in emerging markets should have more people on the ground, according to Cutting Edge Information's Shaylyn Pike.
Companies looking to outsource patient recruitment need to think outside the box, says Cutting Edge Information’s director of research Eric Bolesh.
Outsourcing should play a vital role in any patient recruitment strategy, says Cutting Edge Information’s director of research Eric Bolesh.
Covance has announced it will collaborate on a genome sequencing project with Broad Institute to create genomic resources for a research model.
Software developer CliniWorks says data-mining is key to addressing trial sector’s “Achilles Heel,” patient recruitment.
An evidence-based approach to planning during protocol development is key to successful patient recruitment according to Joseph Kim, director of clinical operations at Shire Pharmaceuticals.
Blue Chip Patient Recruitment says the future of patient sourcing for clinical trials lies in social media.
PPD has launched an iPhone app as part of efforts to use technology for patient recruitment and other clinical trial processes.
Technology use in clinical trials is accelerating and will have a major impact on patient recruitment and other processes, said a PCT panel.
Being proactive and re-establishing relationships with investigators are vital to boosting patient recruitment and retention, said a PCT panel.
Applying a business model based on marketing theory to clinical trials can give a consistent framework for planning and managing patient recruitment, say academics.
CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed.
A pool of research-aware US oncology clinical investigators must be developed to ensure patient recruitment rates meet demand.